178 related articles for article (PubMed ID: 25754767)
1. Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters.
Singh L; Pushker N; Sen S; Singh MK; Chauhan FA; Kashyap S
Clin Exp Ophthalmol; 2015 Aug; 43(6):550-7. PubMed ID: 25754767
[TBL] [Abstract][Full Text] [Related]
2. Expression of CDC25A and CDC25B phosphatase proteins in human retinoblastoma and its correlation with clinicopathological parameters.
Singh L; Pushker N; Sen S; Singh MK; Bakhshi S; Chawla B; Kashyap S
Br J Ophthalmol; 2015 Apr; 99(4):457-63. PubMed ID: 25326518
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of polo-like kinase 1 promotes hyperthermia sensitivity via inactivation of heat shock transcription factor 1 in human retinoblastoma cells.
Yunoki T; Tabuchi Y; Hayashi A; Kondo T
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8353-63. PubMed ID: 24366665
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.
Weichert W; Kristiansen G; Winzer KJ; Schmidt M; Gekeler V; Noske A; Müller BM; Niesporek S; Dietel M; Denkert C
Virchows Arch; 2005 Apr; 446(4):442-50. PubMed ID: 15785925
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
Schwermer M; Dreesmann S; Eggert A; Althoff K; Steenpass L; Schramm A; Schulte JH; Temming P
Clin Exp Ophthalmol; 2017 Apr; 45(3):288-296. PubMed ID: 27647547
[TBL] [Abstract][Full Text] [Related]
6. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
7. Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma.
Juntermanns B; Sydor S; Kaiser GM; Jaradat D; Mertens JC; Sotiropoulos GC; Swoboda S; Neuhaus JP; Meng W; Mathé Z; Baba HA; Canbay A; Paul A; Fingas CD
Liver Int; 2015 Nov; 35(11):2448-57. PubMed ID: 25818805
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma.
Weichert W; Denkert C; Schmidt M; Gekeler V; Wolf G; Köbel M; Dietel M; Hauptmann S
Br J Cancer; 2004 Feb; 90(4):815-21. PubMed ID: 14970859
[TBL] [Abstract][Full Text] [Related]
9. Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1.
Iida M; Matsuda M; Komatani H
Biochem J; 2008 Apr; 411(1):27-32. PubMed ID: 18062778
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of NADPH oxidase-4 as an indicator of reactive oxygen species stress in human retinoblastoma.
Singh L; Saini N; Pushker N; Sen S; Sharma A; Kashyap S
Int J Clin Oncol; 2016 Aug; 21(4):651-657. PubMed ID: 26857459
[TBL] [Abstract][Full Text] [Related]
11. PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma.
Fernández-Aceñero MJ; Cortés D; Gómez del Pulgar T; Cebrián A; Estrada L; Martínez-Useros J; Celdrán A; García-Foncillas J; Pastor C
Pathol Oncol Res; 2016 Apr; 22(2):377-83. PubMed ID: 26577686
[TBL] [Abstract][Full Text] [Related]
12. [Polo like kinase 1 expression and prognostic value in gastric carcinomas].
Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):70-2. PubMed ID: 17253180
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma.
Ma H; Nie C; Chen Y; Li J; Xie Y; Tang Z; Gao Y; Ai S; Mao Y; Sun Q; Lu R
Oncol Res; 2021 Sep; 28(7):745-761. PubMed ID: 33573708
[TBL] [Abstract][Full Text] [Related]
14. Thoughts on the current assessment of Polo-like kinase inhibitor drug discovery.
Strebhardt K; Becker S; Matthess Y
Expert Opin Drug Discov; 2015 Jan; 10(1):1-8. PubMed ID: 25263688
[TBL] [Abstract][Full Text] [Related]
15. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.
Zeng Y; Li N; Liu W; Zeng M; Cheng J; Huang J
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2447-2460. PubMed ID: 32627077
[TBL] [Abstract][Full Text] [Related]
16. Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Cebrián A; Gómez Del Pulgar T; Fernández-Aceñero MJ; Borrero-Palacios A; Del Puerto-Nevado L; Martínez-Useros J; Marín-Arango JP; Caramés C; Vega-Bravo R; Rodríguez-Remírez M; Manzarbeitia F; García-Foncillas J
Pathol Res Pract; 2016 Dec; 212(12):1133-1137. PubMed ID: 27712975
[TBL] [Abstract][Full Text] [Related]
17. Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer.
Tut TG; Lim SH; Dissanayake IU; Descallar J; Chua W; Ng W; de Souza P; Shin JS; Lee CS
PLoS One; 2015; 10(6):e0129313. PubMed ID: 26047016
[TBL] [Abstract][Full Text] [Related]
18. Polo-like kinase 1 as a new target for non-Hodgkin's lymphoma treatment.
Liu L; Zhang M; Zou P
Oncology; 2008; 74(1-2):96-103. PubMed ID: 18547964
[TBL] [Abstract][Full Text] [Related]
19. The role of Plk3 in oncogenesis.
Helmke C; Becker S; Strebhardt K
Oncogene; 2016 Jan; 35(2):135-47. PubMed ID: 25915845
[TBL] [Abstract][Full Text] [Related]
20. Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.
Zhang G; Zhang Z; Liu Z
Tumour Biol; 2013 Jun; 34(3):1887-94. PubMed ID: 23494182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
